These include fast, accurate, and easy to use tests for SARS-CoV-2, the virus causing COVID-19, Flu, MRSA, tuberculosis, and other HAI, sexual health, and oncology diseases. Each test is designed for use on any of the tens of thousands of configurable GeneXpert® Systems placed in hospitals, ER’s, clinics, nursing homes, and other settings worldwide.
With more than 20 FDA-cleared tests (including moderate complexity and CLIA waived tests), Cepheid is your partner for empowering clinicians with fast, accurate results. Learn more at www.cepheid.com.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
